About Us

ADA Newsroom

Get the latest news from ADA, including press releases and research announcements.

Senior couple reading news on laptop

Press Releases

If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.

Recent Press release

American Diabetes Association logo reversed out white on red background
Local Press Release

Back-to-School Wellness Expo Addresses Health Needs in D.C.’s Ward 8

The Collaboration for Equitable Health with Black Nurses
American Diabetes Association logo reversed out white on red background
Local Press Release

The American Diabetes Association and CareFirst BlueCross BlueShield Join Forces to Focus on Diabetes Prevention and Nutrition Education

The American Diabetes Association ® (ADA) and CareFirst
American Diabetes Association logo reversed out white on red background
Press release

Abbott and the American Diabetes Association Collaborate to Drive a Better Understanding of the Role of Nutrition Formulas to Support People with Diabetes and Obesity

The American Diabetes Association ® (ADA) and Abbott

Official Statement

Recent Press release

American Diabetes Association logo reversed out white on red background
Local Press Release

Back-to-School Wellness Expo Addresses Health Needs in D.C.’s Ward 8

The Collaboration for Equitable Health with Black Nurses
American Diabetes Association logo reversed out white on red background
Local Press Release

The American Diabetes Association and CareFirst BlueCross BlueShield Join Forces to Focus on Diabetes Prevention and Nutrition Education

The American Diabetes Association ® (ADA) and CareFirst
American Diabetes Association logo reversed out white on red background
Press release

Abbott and the American Diabetes Association Collaborate to Drive a Better Understanding of the Role of Nutrition Formulas to Support People with Diabetes and Obesity

The American Diabetes Association ® (ADA) and Abbott
Filter by:
Sort by:
Press release

Safety of Linagliptin for Adults with Type 2 Diabetes Who Have High Risk of Cardiovascular and/or Renal Disease Examined in CARMELINA

Linagliptin, when added to usual diabetes care in people with type 2 diabetes (T2D) with increased risk of cardiovascular (CV) and/or…
Published: Tuesday, June 11, 2019
ada-a_comms_logo
Press release

Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease

For people with type 2 diabetes (T2D) and chronic kidney disease (CKD), canagliflozin, an oral, sodium-glucose co-transporter-2 (SGLT2)
Published: Tuesday, June 11, 2019
ada-a_comms_logo
Press release

Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk…
Published: Tuesday, June 11, 2019
ada-a_comms_logo

Meet Our Experts

The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.

CEO Charles
Charles D. Henderson

Chief Executive Officer

Robert Gabbay
Robert Gabbay, MD, PhD

Chief Scientific and Medical Officer 

Lisa Murdock headshot
Lisa Murdock

Chief Advocacy Officer 

Dr. El Sayed
Nuha El Sayed, MD, MMSc

Senior Vice President, Health Care Improvement 

Marlon Pragnell
Marlon Pragnell, PhD

Vice President, Research & Science 

Crystal Woodward
Crystal Woodward, MPS

Managing Director, Legal Advocacy/Safe at School